Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksOXYGENTAPH
resources
OXYGENTAPH

Oxygenta Pharmaceutical Ltd.

BSE: 524636
Sector: Healthcare
Industry: Pharmaceuticals
46.07-0.9 (-1.98%)
23 Oct, 12:00 AM

Annual Reports and Financial Documents

Oxygenta Pharmaceutical Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20132014201520162017201820192020202120222023202420252026
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Quarterly Results—————
Conference Calls——————————————
Presentations——————————————

Corporate Announcements and Regulatory Filings

Oxygenta Pharmaceutical Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201813 Oct 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th September, 2026.
  2. General1 Oct 2026
    Announcement Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015-Purchase Of Land
    Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015.
  3. Closure of Trading Window29 Sept 2026
    Closure of Trading Window
    Closure of trading window for the period ending on 30th September, 2026.
  4. AGM21 Aug 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Disclosure under Regulation 44(3) of SEBI (LODR), Regulations, 2015.
  5. AGM21 Aug 2026
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    Outcome of 33rd Annual General Meeting held on 21.08.2026.
  6. General31 Jul 2026
    Newspaper Advertisement
    Newspaper Advertisement for Notice of AGM scheduled to be held on 21st August, 2026.
  7. AGM30 Jul 2026
    Intimation Of Book Closure And Cut-Off Date For The 33Rd Annual General Meeting Of Oxygenta Pharmaceutical Limited.
    Intimation of Book Closure and Cut-off Date for the AGM
  8. Reg. 34 (1) Annual Report30 Jul 2026
    Reg. 34 (1) Annual Report.
    Submission of 33rd Annual Report for the Financial Year 2025-26 under Regulation 34 of SEBI (LODR), Regulations, 2015
  9. AGM30 Jul 2026
    Submission Of Notice Of 33Rd Annual General Meeting For The Finanical Year 2025-26.
    Notice of 33rd Annual General Meeting for the Financial Year 2025-26.
  10. Change in Management27 Jul 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Appointment of Cost Auditor for the Financial Year 2026-27.
  11. Outcome of Board Meeting27 Jul 2026
    Board Meeting Outcome for Outcome For The Board Meeting Held On 27.07.2026
    Un-audited Financial results for the Quarter ended 30.06.2026.
  12. Board Meeting Rescheduled24 Jul 2026
    Update on board meeting
    The Board Meeting to be held on 25/07/2026 has been revised to 27/07/2026 Postponement of the Board Meeting to be held on Saturday, 25th July, 2026 and rescheduling of the board meeting ....
  13. Board Meeting22 Jul 2026
    Board Meeting Intimation for The Meeting To Be Held On Saturday, 25Th Day Of July, 2026
    Oxygenta Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2026 ,inter alia, to consider and approve 1. Unaudited Financial ....
  14. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201814 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Compliance as per Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th June, 2026.
  15. Closure of Trading Window24 Jun 2026
    Closure of Trading Window
    Closure of trading window for the period ending 30.06.2026.
  16. Reg.24(A)-Annual Secretarial Compliance26 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    Annual Secretarial Compliance Report for the year ended 31.03.2026 pursuant to Regulation 24A of SEBI (LODR) Regulations, 2018.
  17. Change in Management23 May 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Change in Management by way of appointment of Additional Directors and Internal Auditor.
  18. Outcome of Board Meeting23 May 2026
    Board Meeting Outcome for Outcome Of The Board Meeting Held On 23Rd May, 2026
    Outcome of the Board meeting held on 23rd May, 2026.
  19. Board Meeting19 May 2026
    Board Meeting Intimation for The Meeting To Be Held On Saturday, 23Rd May, 2026.
    Oxygenta Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2026 ,inter alia, to consider and approve 1. Audited Financial ....
  20. Format of the Annual Disclosure to be made by an entity identified as a LC : Annexure B227 Apr 2026
    Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
    <b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....

Frequently Asked Questions

Where can I download the annual report of Oxygenta Pharmaceutical Ltd.?
Annual reports of Oxygenta Pharmaceutical Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Oxygenta Pharmaceutical Ltd.?
Quarterly earnings results and presentations of Oxygenta Pharmaceutical Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Oxygenta Pharmaceutical Ltd. publish earnings call transcripts?
Earnings call transcripts of Oxygenta Pharmaceutical Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Oxygenta Pharmaceutical Ltd.?
Investor presentations and annual day presentations of Oxygenta Pharmaceutical Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Oxygenta Pharmaceutical Ltd.?
Corporate announcements and regulatory filings of Oxygenta Pharmaceutical Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Oxygenta Pharmaceutical Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Oxygenta Pharmaceutical Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Oxygenta Pharmaceutical Ltd.?
The ISIN (International Securities Identification Number) of Oxygenta Pharmaceutical Ltd. is INE102E01018. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Oxygenta Pharmaceutical Ltd. listed?
Oxygenta Pharmaceutical Ltd. is listed on NSE and BSE. The NSE symbol is OXYGENTAPH and the BSE code is -.
Where can I find the shareholding pattern of Oxygenta Pharmaceutical Ltd.?
The quarterly shareholding pattern of Oxygenta Pharmaceutical Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Oxygenta Pharmaceutical Ltd. on Sharpely?
Share price data for Oxygenta Pharmaceutical Ltd. is updated as of 23 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.